Alaunos Therapeutics (TCRT) Operating Margin Growth (1y) (2012 - 2025)
Alaunos Therapeutics (TCRT) Operating Margin Growth (1y) (2012 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -1,651.00 |
| 10 | Alaunos Therapeutics | 4.28 Mn | 4.16 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.14 Mn |
| Mar 31, 2025 | 11.96 Mn |
| Dec 31, 2024 | 77.60 Mn |
| Jun 30, 2024 | 17.04 Mn |
| Dec 31, 2023 | -87.24 Mn |
| Dec 31, 2022 | 63.00 Mn |
| Sep 30, 2022 | 531,812.00 |
| Mar 31, 2018 | -1.02 Mn |
| Dec 31, 2017 | -14,559.00 |
| Sep 30, 2017 | -13,542.00 |
| Jun 30, 2017 | 691,886.00 |
| Mar 31, 2017 | -26,297.00 |
| Dec 31, 2016 | -20,163.00 |
| Sep 30, 2016 | 28,898.00 |
| Jun 30, 2016 | -250,399.00 |
| Mar 31, 2016 | 2.81 Mn |
| Dec 31, 2015 | 262,236.00 |
| Sep 30, 2015 | 91,461.00 |
| Jun 30, 2015 | 35,872.00 |
| Mar 31, 2015 | -2.39 Mn |